Zacks Investment Research on MSN11h
GILD Stock Up on Q4 Earnings and Sales Beat & Upbeat '25 GuidanceGilead Sciences, Inc. GILD reported better-than-expected fourth-quarter results and provided an upbeat guidance for 2025. Adjusted earnings per share (EPS) of $1.90 beat the Zacks Consensus Estimate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback